Global First Approval For Takeda's Dengue Vaccine, In Indonesia
Set To Open Door To Wider Vaccine Use?
Takeda’s dengue vaccine Qdenga has received its global first approval in Indonesia, as Qdenga, also marking the first time for the firm to market a vaccine outside Japan and potentially paving the way to wider global use of vaccines for the mosquito-borne disease following setbacks for earlier contenders.
